東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Squamous cell carcinoma = molecular ...

Warnakulasuriya, Saman.

FindBook

Google Book

Amazon

博客來

Squamous cell carcinoma = molecular therapeutic targets /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Squamous cell carcinoma/ edited by Saman Warnakulasuriya, Zakir Khan.
其他題名:	molecular therapeutic targets /
其他作者:	Warnakulasuriya, Saman.
出版者:	Dordrecht :Springer Netherlands : : 2017.,
面頁冊數:	xii, 281 p. :ill., digital ;24 cm.
內容註:	Preface -- Foreword -- Introduction- The biology and pathology of squamous cell carcinomata in the head and neck -- Cancer Stem Cells - Biopathology with reference to Head & Neck Cancers -- Hypoxia in head and neck cancer -- Genetic aberrations and molecular pathways in head and neck cancer -- p53 in Head and Neck Squamous Cell Carcinoma -- Blockage of EGFR pathway for anticancer therapy in squamous cell carcinoma of the head and neck -- Targeting the mTOR signaling circuitry in head and neck cancer -- Survivin as a Therapeutic Target in Squamous Cell Carcinoma -- MicroRNA: utility as biomarkers and therapeutic targets in squamous cell carcinoma -- Envoi - An appraisal of Targeted Therapies for Head and Neck Cancer -- Index.
Contained By:	Springer eBooks
標題:	Squamous cell carcinoma. -
電子資源:	http://dx.doi.org/10.1007/978-94-024-1084-6
ISBN:	9789402410846

Squamous cell carcinoma = molecular therapeutic targets /
Squamous cell carcinomamolecular therapeutic targets /[electronic resource] :edited by Saman Warnakulasuriya, Zakir Khan. - Dordrecht :Springer Netherlands :2017. - xii, 281 p. :ill., digital ;24 cm.

Preface -- Foreword -- Introduction- The biology and pathology of squamous cell carcinomata in the head and neck -- Cancer Stem Cells - Biopathology with reference to Head & Neck Cancers -- Hypoxia in head and neck cancer -- Genetic aberrations and molecular pathways in head and neck cancer -- p53 in Head and Neck Squamous Cell Carcinoma -- Blockage of EGFR pathway for anticancer therapy in squamous cell carcinoma of the head and neck -- Targeting the mTOR signaling circuitry in head and neck cancer -- Survivin as a Therapeutic Target in Squamous Cell Carcinoma -- MicroRNA: utility as biomarkers and therapeutic targets in squamous cell carcinoma -- Envoi - An appraisal of Targeted Therapies for Head and Neck Cancer -- Index.

This edited volume is about novel targeted therapies for the treatment of advanced neoplasms of the head and neck (HNSCC) with particular reference to oral squamous cell carcinomas and covers specific fields of cancer genetics and genomics for personalized medicine. The landmark studies from the HNSCC Cancer Genome Anatomy (TCGA) and the cancer Genome Atlas 2015 have revealed the multiplicity and diversity of genetic alterations in HNSCC. This remarkable body of information has elucidated novel druggable targets (eg. EGFR, mTOR, p53, survivin and aberrant microRNA) for therapeutic interventions in head and neck cancer. Readers will discover the importance of the biology and pathology of squamous cell carcinomas, the role of cancer stem cells and other factors that contribute to resistance to curative therapies such as hypoxia. We present an in-depth analysis of the HNSCC oncogenome describing the distinct molecular alterations in squamous cell carcinomas, which participate in specific molecular pathways whose dysregulation may contribute to most HNSCC cases. Final chapters of the book elucidate how these important cancer-driving molecular events and molecular pathways could be targeted to treat head and neck cancers and their therapeutic applications for targeted therapies based on clinical trials reported worldwide. This book is aimed at a broad audience, including scientists, physicians, surgeons, and post graduate students engaged in oncology and provide the readers with an up-to-date, interdisciplinary knowledge and tools to better understand the evolving areas of targeted gene therapy and the key concept of personalized medicine in head and neck cancer.

ISBN: 9789402410846

Standard No.: 10.1007/978-94-024-1084-6doiSubjects--Topical Terms:

1531072
Squamous cell carcinoma.

LC Class. No.: RC280.S5

Dewey Class. No.: 616.99477

Squamous cell carcinoma = molecular therapeutic targets /
LDR:03395nmm a2200313 a 4500 001 2092496
003 DE-He213
005 20170327140705.0
006 m d
007 cr nn 008maaau
008 171117s2017 ne s 0 eng d
020 $a 9789402410846 $q (electronic bk.)
020 $a 9789402410839 $q (paper)
024 7 $a 10.1007/978-94-024-1084-6 $2 doi
035 $a 978-94-024-1084-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.S5
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 616.99477 $2 23
090 $a RC280.S5 $b S773 2017
245 0 0 $a Squamous cell carcinoma $h [electronic resource] : $b molecular therapeutic targets / $c edited by Saman Warnakulasuriya, Zakir Khan.
260 $a Dordrecht : $b Springer Netherlands : $b Imprint: Springer, $c 2017.
300 $a xii, 281 p. : $b ill., digital ; $c 24 cm.
505 0 $a Preface -- Foreword -- Introduction- The biology and pathology of squamous cell carcinomata in the head and neck -- Cancer Stem Cells - Biopathology with reference to Head & Neck Cancers -- Hypoxia in head and neck cancer -- Genetic aberrations and molecular pathways in head and neck cancer -- p53 in Head and Neck Squamous Cell Carcinoma -- Blockage of EGFR pathway for anticancer therapy in squamous cell carcinoma of the head and neck -- Targeting the mTOR signaling circuitry in head and neck cancer -- Survivin as a Therapeutic Target in Squamous Cell Carcinoma -- MicroRNA: utility as biomarkers and therapeutic targets in squamous cell carcinoma -- Envoi - An appraisal of Targeted Therapies for Head and Neck Cancer -- Index.
520 $a This edited volume is about novel targeted therapies for the treatment of advanced neoplasms of the head and neck (HNSCC) with particular reference to oral squamous cell carcinomas and covers specific fields of cancer genetics and genomics for personalized medicine. The landmark studies from the HNSCC Cancer Genome Anatomy (TCGA) and the cancer Genome Atlas 2015 have revealed the multiplicity and diversity of genetic alterations in HNSCC. This remarkable body of information has elucidated novel druggable targets (eg. EGFR, mTOR, p53, survivin and aberrant microRNA) for therapeutic interventions in head and neck cancer. Readers will discover the importance of the biology and pathology of squamous cell carcinomas, the role of cancer stem cells and other factors that contribute to resistance to curative therapies such as hypoxia. We present an in-depth analysis of the HNSCC oncogenome describing the distinct molecular alterations in squamous cell carcinomas, which participate in specific molecular pathways whose dysregulation may contribute to most HNSCC cases. Final chapters of the book elucidate how these important cancer-driving molecular events and molecular pathways could be targeted to treat head and neck cancers and their therapeutic applications for targeted therapies based on clinical trials reported worldwide. This book is aimed at a broad audience, including scientists, physicians, surgeons, and post graduate students engaged in oncology and provide the readers with an up-to-date, interdisciplinary knowledge and tools to better understand the evolving areas of targeted gene therapy and the key concept of personalized medicine in head and neck cancer.
650 0 $a Squamous cell carcinoma. $3 1531072
650 1 4 $a Biomedicine. $3 890831
650 2 4 $a Cancer Research. $3 891172
700 1 $a Warnakulasuriya, Saman. $3 3226424
700 1 $a Khan, Zakir. $3 3226425
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-94-024-1084-6
950 $a Biomedical and Life Sciences (Springer-11642)